Metabolic syndrome, defined as the clustering of several metabolic disorders including obesity (waist circumference ${\geq}90$ if male or ${\geq}80$ if female, cm), dyslipidemia ($TG{\geq}150$ or HDL-C<40 if male or <50 if female, mg/dl), hypert...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A103781412
정재훈 (충북대학교) ; 이보름 (충북대학교) ; 임성진 (충북대학교) ; 장제관 (충북대학교) ; 이명구 (충북대학교) ; 이종길 (충북대학교) ; 임성실 (충북대학교) ; Chung, Jae-Hun ; Lee, Bo-Reum ; Lim, Sung-Jin ; Jang, Je-Kwan ; Lee, Myung-Koo ; Lee, Chong-Kil ; Lim, Sung-Cil
2009
Korean
KCI등재
학술저널
19-24(6쪽)
0
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
Metabolic syndrome, defined as the clustering of several metabolic disorders including obesity (waist circumference ${\geq}90$ if male or ${\geq}80$ if female, cm), dyslipidemia ($TG{\geq}150$ or HDL-C<40 if male or <50 if female, mg/dl), hypert...
Metabolic syndrome, defined as the clustering of several metabolic disorders including obesity (waist circumference ${\geq}90$ if male or ${\geq}80$ if female, cm), dyslipidemia ($TG{\geq}150$ or HDL-C<40 if male or <50 if female, mg/dl), hypertension ($BP{\geq}130/85mmHg$) and hyperglycemia (fasting plasma $glucose{\geq}110mg/dl$), increases the cardiovascular risk of the general population. Recently, risk of this syndrome arises in young adults world widely. Therefore, we randomly selected and evaluated the risk of metabolic syndrome of total 43 people (group I-22, group II-21) for 2 years. Group I was 22 peoples (15 males, 7 females) with age of 22 thru 35 year old (average 28 year old) and group II was 21 people (19 male, 2 female) with age of 22 thur 32 years old (average 24 year old) in Cheongju area from March 1st thru 30th of 2008 in Cheongju area from September 1st thru 30th of 2007 in order to find out how serious this phenomenon is in young adult of Korea. 13.95% (n=7) of total people has a metabolic syndrome by NCEP/ATPIII definition among this group (group I-6, group II-1). Those of 6 have 3 or over risk factor for metabolic syndrome such as obesity, hypertension, fasting blood glucose and hypetriglyceridemia at the same time (group I-5, group II-1). Group I have more risk factor because of more higher age than group II. Therefore we need aggressively to monitor and provide them for early diagnosis, educational programs and assistance for lifestyle changes in order to prevent metabolic syndrome among young adults.
참고문헌 (Reference)
1 Grassi, G, "and vascular stiffness: when body fat has an adverse impact on arterial dynamics" 23 : 1789-, 2005
2 "World Health Organization. Geneva, World Health Organization : Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation" 916 : 2003
3 Reilly, M. P, "The metabolic syndrome: more than sum of its parts?" 108 : 1546-, 2003
4 "The US National Cholesterol Education Program (NCEP) Expert Panel: Third report of the National Cholesterol Education Program Expert Panel on Detection, Evalution, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III (ATPIII) final report" 3143-, 2002
5 Westerbacka, J., "Resistance to acute insulin induced decreases in large artery stiffness accompanies the insulin resistance syndrome" 86 : 5262-, 2001
6 Kawamoto, R., "Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis" 45 : 605-, 2006
7 Kosch, M., "Relationship between muscle sympathetic nerve activity and large artery mechanical vessel wall properties in renal transplant patients" 20 : 501-, 2002
8 Tapia Ceballos, L., "Prevalence of metabolic syndrome and its components in obese children and adolescents" 67 : 352-, 2007
9 WHO, "Physical status: The use and interpretation of anthropometry. WHO Technical Report Series" 1995
10 김현창, "Normal Serum Aminotransferase Levels and the Metabolic Syndrome: Korean National Health and Nutrition Examination Surveys" 연세대학교의과대학 47 (47): 542-550, 2006
1 Grassi, G, "and vascular stiffness: when body fat has an adverse impact on arterial dynamics" 23 : 1789-, 2005
2 "World Health Organization. Geneva, World Health Organization : Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation" 916 : 2003
3 Reilly, M. P, "The metabolic syndrome: more than sum of its parts?" 108 : 1546-, 2003
4 "The US National Cholesterol Education Program (NCEP) Expert Panel: Third report of the National Cholesterol Education Program Expert Panel on Detection, Evalution, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III (ATPIII) final report" 3143-, 2002
5 Westerbacka, J., "Resistance to acute insulin induced decreases in large artery stiffness accompanies the insulin resistance syndrome" 86 : 5262-, 2001
6 Kawamoto, R., "Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis" 45 : 605-, 2006
7 Kosch, M., "Relationship between muscle sympathetic nerve activity and large artery mechanical vessel wall properties in renal transplant patients" 20 : 501-, 2002
8 Tapia Ceballos, L., "Prevalence of metabolic syndrome and its components in obese children and adolescents" 67 : 352-, 2007
9 WHO, "Physical status: The use and interpretation of anthropometry. WHO Technical Report Series" 1995
10 김현창, "Normal Serum Aminotransferase Levels and the Metabolic Syndrome: Korean National Health and Nutrition Examination Surveys" 연세대학교의과대학 47 (47): 542-550, 2006
11 Grandi, A. M., "Metabolic syndrome and morphofunctional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects" 19 : 199-, 2006
12 Laaksonen, D. E, "Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study" 156 : 1070-, 2002
13 Scuteri, A., "Metabolic syndrome amplifies the ageassociated increases in vascular thckness and stiffness" 43 : 1388-, 2004
14 Malik, S., "Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults" 110 : 1245-, 2004
15 "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel)" 285 : 2486-, 2001
16 Solymoss, B. C., "Effect of increasing metabolic syndrome score on atherosclertic risk profile and coronary artery disease angiogtaphic severity" 93 : 159-, 2004
17 Isomaa, B., "Cardiovascular morbidity and mortality associated with the metabolic syndrome" 24 : 683-, 2001
2-알킬-2,3-다이하이드로-1H-2-아자사이클로펜타[b]안트라센-5,10-디온계 유도체 합성 및 세포독성
Maackia fauriei 유래 렉틴의 중성당 및 아미노당 조성
외래 비만 클리닉에서 행해지는 비만 치료의 목적 및 타당성에 관한 평가
어성초로부터 분리된 Quercetin의 카드뮴에 대한 독성억제효과
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2027 | 평가예정 | 재인증평가 신청대상 (재인증) | |
2021-01-01 | 평가 | 등재학술지 유지 (재인증) | ![]() |
2018-01-01 | 평가 | 등재학술지 유지 (등재유지) | ![]() |
2015-01-01 | 평가 | 등재학술지 유지 (등재유지) | ![]() |
2011-01-01 | 평가 | 등재학술지 유지 (등재유지) | ![]() |
2009-01-01 | 평가 | 등재학술지 유지 (등재유지) | ![]() |
2007-01-01 | 평가 | 등재학술지 유지 (등재유지) | ![]() |
2004-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | ![]() |
2003-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | ![]() |
2002-01-01 | 평가 | 등재후보학술지 유지 (등재후보1차) | ![]() |
1999-07-01 | 평가 | 등재후보학술지 선정 (신규평가) | ![]() |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.2 | 0.2 | 0.22 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.23 | 0.18 | 0.403 | 0.02 |